Spots Global Cancer Trial Database for multiple endocrine neoplasia type 1

Every month we try and update this database with for multiple endocrine neoplasia type 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors	NCT05554744	Multiple Endocr... Pancreatic Neur...	EUS-guided fine...	18 Years - 85 Years	Guangxi Medical University
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	NCT02831179	Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis...	Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom...	18 Years -	Vanderbilt-Ingram Cancer Center
Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients	NCT05037461	Neuroendocrine ... Multiple Endocr...	High-dose-high ...	18 Years -	UMC Utrecht
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients	NCT05037461	Neuroendocrine ... Multiple Endocr...	High-dose-high ...	18 Years -	UMC Utrecht
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors	NCT03950609	Advanced Carcin... Digestive Syste... Multiple Endocr... Neuroendocrine ... Unresectable Ca...	Everolimus Lenvatinib	18 Years -	M.D. Anderson Cancer Center
EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors	NCT05554744	Multiple Endocr... Pancreatic Neur...	EUS-guided fine...	18 Years - 85 Years	Guangxi Medical University
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	NCT02831179	Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis...	Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom...	18 Years -	Vanderbilt-Ingram Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: